October #95 : 60% of HIVers Now Survive Lymphoma - by David Gelman, MD

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

The Clock Watchers

After Ibn Zuhur

Stayin’ Alive: A Game Plan

I Wanna New Drug!

In Cold Blood

Unfine China

Maine Idea

Bayer's BIG Headache

Neg & Pos

Gone Shopping

The Bug Stops Here

Milestones

Documania

For Pete's Sake

Wake-Up Call

Heavenly & Hazardous

Shock and Blah

Publisher's Letter

Mailbox

O Lady Liberate:

O Cash up Front:

Tastes Great! Less Filling!

Tat Caveat

Only A Test

Lipodystrophy

New Meds On The Shelf

Book Report

60% of HIVers Now Survive Lymphoma

Zip Your Lipids

Tea Cells

Paris When It Sizzled

Playing It Safe And Sexy

HEP Or HIV?

The Soprano

Dementia

Butch And Moan

Toxic Avengers



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

October 2003

60% of HIVers Now Survive Lymphoma

by David Gelman, MD

The incidence of non-Hodgkins lymphoma—a deadly cancer of the
lymphocyte T and B cells that hits more than 4 percent of all HIVers—hasn’t fallen in the HAART era. But now it appears that the HIV “cocktail hour” has poured a glass half full: HIVers now seem to be contracting lymphoma that is more drug-responsive than before HAART. The Center for Cancer Research at the National Cancer Institute has scored a 60 percent survival rate in positive patients with aggressive B-cell lymphomas after slightly more than four years. In the past, survival rates for HIV-related lymphoma reached only 20 to 40 percent after three years of cancer treatment (the rate varies by type of tumor). The lead study author, Wyndham Wilson, MD, reports, “There appears to have been a shift in the pathobiology of AIDS-related tumors, due to the improvement in immune function with HAART, [so that] the lymphomas are more sensitive to treatment and hence more curable.” It helps that chemotherapy can now be dosed by continuous infusion over days rather than all in a few hours. So, Wilson adds, “AIDS lymphoma today should be considered highly curable with appropriate treatment.” Cause for celebration.




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.